185 related articles for article (PubMed ID: 32320927)
21. Pharmacotherapy for pediatric soft-tissue sarcomas.
Casanova M; Ferrari A
Expert Opin Pharmacother; 2011 Mar; 12(4):517-31. PubMed ID: 21306288
[TBL] [Abstract][Full Text] [Related]
22. Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.
Noujaim J; Thway K; Sheri A; Keller C; Jones RL
Int J Surg Pathol; 2016 Feb; 24(1):5-15. PubMed ID: 26399578
[TBL] [Abstract][Full Text] [Related]
23. Molecularly targeted therapies in adult soft tissue sarcomas: present approach and future directions.
Aranha O; Agulnik M
Expert Opin Ther Targets; 2008 Feb; 12(2):197-207. PubMed ID: 18208368
[TBL] [Abstract][Full Text] [Related]
24. New therapies in soft tissue sarcoma.
Vincenzi B; Frezza AM; Santini D; Tonini G
Expert Opin Emerg Drugs; 2010 Jun; 15(2):237-48. PubMed ID: 20465449
[TBL] [Abstract][Full Text] [Related]
25. Targeted therapies in soft tissue sarcomas.
Judson I
Ann Oncol; 2010 Oct; 21 Suppl 7():vii277-80. PubMed ID: 20943628
[TBL] [Abstract][Full Text] [Related]
26. Histology- and non-histology-driven therapy for treatment of soft tissue sarcomas.
Casali PG
Ann Oncol; 2012 Sep; 23 Suppl 10():x167-9. PubMed ID: 22987955
[TBL] [Abstract][Full Text] [Related]
27. Targeted therapies for sarcomas: new roles for the pathologist.
Al-Zaid T; Somaiah N; Lazar AJ
Histopathology; 2014 Jan; 64(1):119-33. PubMed ID: 24117526
[TBL] [Abstract][Full Text] [Related]
28. Targeting mutant kinases in gastrointestinal stromal tumors: a paradigm for molecular therapy of other sarcomas.
Heinrich MC; Corless CL
Cancer Treat Res; 2004; 120():129-50. PubMed ID: 15217222
[No Abstract] [Full Text] [Related]
29. Role of genetic and molecular profiling in sarcomas.
Norberg SM; Movva S
Curr Treat Options Oncol; 2015 May; 16(5):24. PubMed ID: 25939540
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy of advanced soft-tissue sarcomas in adults.
Pinedo HM; Kenis Y
Cancer Treat Rev; 1977 Jun; 4(2):67-86. PubMed ID: 329988
[No Abstract] [Full Text] [Related]
31. Updating progress in sarcoma therapy with mTOR inhibitors.
Blay JY
Ann Oncol; 2011 Feb; 22(2):280-7. PubMed ID: 20591820
[TBL] [Abstract][Full Text] [Related]
32. Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.
Schöffski P; Ray-Coquard IL; Cioffi A; Bui NB; Bauer S; Hartmann JT; Krarup-Hansen A; Grünwald V; Sciot R; Dumez H; Blay JY; Le Cesne A; Wanders J; Hayward C; Marreaud S; Ouali M; Hohenberger P;
Lancet Oncol; 2011 Oct; 12(11):1045-52. PubMed ID: 21937277
[TBL] [Abstract][Full Text] [Related]
33. Olaratumab in soft tissue sarcoma - Current status and future perspectives.
Antoniou G; Lee ATJ; Huang PH; Jones RL
Eur J Cancer; 2018 Mar; 92():33-39. PubMed ID: 29413687
[TBL] [Abstract][Full Text] [Related]
34. New Drug Approvals for Sarcoma in the Last 5 Years.
Thirasastr P; Brahmi M; Dufresne A; Somaiah N; Blay JY
Surg Oncol Clin N Am; 2022 Jul; 31(3):361-380. PubMed ID: 35715139
[TBL] [Abstract][Full Text] [Related]
35. Role of chemotherapy in patients with soft tissue sarcomas.
Maki RG
Expert Rev Anticancer Ther; 2004 Apr; 4(2):229-36. PubMed ID: 15056053
[TBL] [Abstract][Full Text] [Related]
36. ErbB receptors as prognostic and therapeutic drug targets in bone and soft tissue sarcomas.
Wang H; Yang Q; Fu Z; Zuo D; Hua Y; Cai Z
Cancer Invest; 2014 Dec; 32(10):533-42. PubMed ID: 25347730
[TBL] [Abstract][Full Text] [Related]
37. Ridaforolimus in advanced or metastatic soft tissue and bone sarcomas.
Mita MM; Gong J; Chawla SP
Expert Rev Clin Pharmacol; 2013 Sep; 6(5):465-82. PubMed ID: 23971829
[TBL] [Abstract][Full Text] [Related]
38. Role of new chemotherapy agents in soft tissue sarcoma.
von Mehren M
J Natl Compr Canc Netw; 2005 Mar; 3(2):198-205. PubMed ID: 19817029
[TBL] [Abstract][Full Text] [Related]
39. New therapeutic targets in soft tissue sarcoma.
Demicco EG; Maki RG; Lev DC; Lazar AJ
Adv Anat Pathol; 2012 May; 19(3):170-80. PubMed ID: 22498582
[TBL] [Abstract][Full Text] [Related]
40. [Drug therapy for soft tissue sarcoma].
Zhang X
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(37):2889-2892. PubMed ID: 31607015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
